Labshake search
Citations for Bio X Cell :
1 - 50 of 174 citations for lefty A TGF beta 4 Human HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... anti-IFN-γ and anti-TGF-β (BioxCell) were used at 10 μg/mL ...
-
Single cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironmentbioRxiv - Genomics 2020Quote: ... anti-TGF-β (10 mg/kg; mouse IgG1 clone 1D11, BioXCell), or a combination of anti-PD-L1 plus anti-TGF-β ...
-
bioRxiv - Immunology 2023Quote: ... and anti-TGF-β1 (5 µg/ml, clone 1D11.16.8, BioXCell, BE0057). Th17 ...
-
Single cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironmentbioRxiv - Genomics 2020Quote: ... anti-TGF-β (mouse IgG1 clone 1D11 from BioXCell, 10 mg/kg), or a combination of anti-PD-L1 (2 mg/kg ...
-
bioRxiv - Immunology 2022Quote: ... TGF-β Ab 1D11 (N=13, 10 mg/kg, BP0057 lot#704719J1, BioXCell, West Lebanon, NH).
-
bioRxiv - Cell Biology 2023Quote: ... mouse anti-6-His (Bio X Cell, AB_2687790) was used for western blot (3 µg/ml) ...
-
Single cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironmentbioRxiv - Genomics 2020Quote: ... or a combination of anti-PD-L1 (2 mg/kg) and anti-TGF-β (mouse IgG1 clone 1D11 from BioXCell, 10 mg/kg). Tumor volumes and body weight were measured in a blinded fashion twice a week ...
-
bioRxiv - Immunology 2019Quote: ... anti-human CD3 (OKT3, Bio X cell, anti-human CD28 (9.3 Bio X Cell), anti-human CD45 (REA747 ...
-
bioRxiv - Immunology 2019Quote: ... anti-human CD3 (OKT3, Bio X cell, anti-human CD28 (9.3 Bio X Cell), anti-human CD45 (REA747 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-human CD3 antibody (BioXCell) was added at a final concentration of 1 μg/106 cells to avoid potential graft-versus-host disease ...
-
bioRxiv - Cancer Biology 2023Quote: ... Anti-human CD3 antibody (BioXCell) was added at a final concentration of 1 μg/106 cells to avoid potential graft-versus-host disease ...
-
bioRxiv - Microbiology 2021Quote: ... or human IgG1 isotype (BioXCell, #BE0297) (as negative control ...
-
bioRxiv - Immunology 2021Quote: ... human IgG1 isotype control (BE0297, BioXcell) at 50ug/mL ...
-
bioRxiv - Immunology 2021Quote: ... human IgG1 isotype control (BE0297, BioXcell) 25ug/mL ...
-
bioRxiv - Microbiology 2021Quote: ... or human IgG1 isotype control (BioXCell, #BE0297) for 30 min at 4°C ...
-
bioRxiv - Immunology 2020Quote: ... Anti-human IFNγ (Bio X Cell, BE0235) or anti-human CXCL10 (ThermoFisher Scientific ...
-
bioRxiv - Immunology 2020Quote: ... anti-human CD3(UCHT1, Bio X Cell) anti-mouse CD28(37.51 ...
-
bioRxiv - Immunology 2020Quote: ... and/or human CD8α (Bioxcell, OKT-8) three days prior to first treatment and concurrently with subsequent treatments.
-
bioRxiv - Immunology 2020Quote: ... and anti-human CD28(9.3, Bio X Cell) were used for T cell activation ...
-
bioRxiv - Systems Biology 2023Quote: The InVivoMAB human IgG1 isotype control antibody (BioXCell) purified from human myeloma serum was diluted in PBS buffer ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2023Quote: ... or anti-human NKG2D (Clone 1D11, BioXCell Catalogue #BE0351) were added 30 to T cells 30 minutes prior to coculture with tumor cells ...
-
Versatile and Robust method for Antibody Conjugation to Nanoparticles with High Targeting EfficiencybioRxiv - Biochemistry 2021Quote: Anti-human EGFR (αEGFR, monoclonal, cat. BE0278) and anti-human CD44 (αCD44, monoclonal, hermes-1, cat. BE0039) were purchased from Bio X Cell (Lebanon). Tetraethyl orthosilicate (TEOS ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Immunology 2020Quote: ... Purified anti-mouse/human integrin β7 (FIB504) was from BioXCell. Carboxyfluorescein succinimidyl ester (CFSE) ...
-
bioRxiv - Immunology 2020Quote: ... weekly with 100μg of anti-human PD-1 (Bioxcell, J116). All treatments were administered together on the same day.
-
bioRxiv - Immunology 2020Quote: ... human IgG1 Isotype control mAb (BioXcell, Labanon, NH; n=6), or PBS (n=5) ...
-
bioRxiv - Cancer Biology 2022Quote: ... as well as anti-human PD-1 (clone pembrolizumab, BioXcell), MEKi trametinib (LSBiosciences ...
-
bioRxiv - Genetics 2024Quote: ... or anti-human PD1 antibody (BioXCell # BE0188, 10 μg/ml) was added during co-culture with EGFR CAR-T for blocking/neutralization.
-
bioRxiv - Immunology 2024Quote: ... or 10μg/mL human IgG4 isotype control antibody (BioXCell CP147) prior to co-culture with target cells ...
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Immunology 2020Quote: ... The hmAb 1069D6 or a human myeloma IgG1 (BioXcell, Labanon, NH) were used as an isotype control ...
-
bioRxiv - Immunology 2023Quote: ... anti-human CD40 (5 μg/mL, Clone: G28.5, Bio X Cell), and IL-21 (10 ng/mL ...
-
bioRxiv - Immunology 2023Quote: ... with the monoclonal antibody against human CD8 (clone OKT-8; BioXCell). The initial injection was 75 µg ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (10 µg/ml, BioXCell). Th1 cells were then cultured ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 Ab (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...